It has been shown that CEA is highly sensitive to gastric cancer and its changes correlate with the sensitivity of gastric cancer to chemotherapy, showing great benefit in prognostic assessment and efficacy observation. The gene discussed is CEACAM5; the disease is gastric cancer.